Foresite Capital Management III’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-346,281	Closed	-$4.44M	–	31
2017 Q1	$4.44M	Hold	346,281	–	–	1.7%	12
2016 Q4	$7.62M	Hold	346,281	–	–	3.31%	9
2016 Q3	$6.29M	Buy	+346,281	New	+$6.29M	2.94%	9